Global HIV Therapeutics Market

1. Summary

The Global HIV Therapeutics Market was valued at $39.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.1% CAGR, to an estimated market size of $50.0 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global HIV therapeutics market encompasses the development, production, and distribution of antiretroviral therapies (ART) and pharmaceutical interventions designed to manage the Human Immunodeficiency Virus (HIV), suppress viral loads, and prevent the progression to AIDS.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the HIV Therapeutics Market in the period 2025-30:

• A significant market shift toward long-acting injectables is improving patient adherence by reducing dosing frequency compared to daily oral regimens.
• The adoption of Single Tablet Regimens (STR) continues to dominate the market by consolidating multiple medications to simplify treatment.
• Integration of Artificial Intelligence (AI) and machine learning is accelerating drug discovery and optimizing personalized treatment plans.
• Increasing government initiatives and global funding programs are expanding access to antiretroviral therapy in low- and middle-income countries.
• The rising prevalence of drug-resistant HIV strains is driving research and development into novel therapeutic classes and salvage therapies.
• Strategic collaborations and alliances between major pharmaceutical firms and generic manufacturers are enhancing global drug accessibility.
• Advancements in point-of-care diagnostics are facilitating earlier HIV detection, leading to faster initiation of therapeutic interventions.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: